Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Steven Fliesler, PhD

Xiuqian Mu, MD, PhD

  • Regulation of mRNA decay in retinal development and maintenance. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,024,085. 4/1/2020-3/1/2024.
  • Regulatory mechanisms for retinal ganglion cell genesis. Xiuqian Mu (Principal Investigator). National Institutes of Health. $1,960,167. 9/1/2017-5/1/2022.
  • Generation of retinal ganglion cells by direct reprograming. Xiuqian Mu (Principal Investigator). BrightFocus Foundation. $150,000. 6/1/2016-5/1/2018.

Sangita Patel, MD, PhD

  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Sangita Patel (Co-Investigator), Michael Duffey (Co-Investigator), Mark Parker (Principal Investigator). National Institutes of Health. $1,972,804. 2/1/2018-1/1/2023.

Sarah Zhang, MD

  • Molecular Mechanisms of Severe Diabetic Retinopathy. Sarah Zhang (Principal Investigator). NIH. 2/1/2020-1/1/2024.
  • Targeting Neuroinflammation for RGC Protection in Glaucoma. Sarah Zhang (Principal Investigator). BrightFocus Foundation. 7/1/2019-6/1/2021.
  • ER stress and diabetic retinopathy (Admin Supplements). Sarah Zhang (Principal Investigator). NIH, NEI. 9/1/2018-8/1/2020.
  • ER stress and diabetic retinopathy. Sarah Zhang (Principal Investigator). NIH, NEI. 9/1/2010-2/1/2024.